ALK and anaplastic large cell lymphoma: Given the efficacy and tolerability of crizotinib in relapsed ALCL, the phase 2 ANHL12P1 trial examined the efficacy and safety of crizotinib in combination with chemotherapy in paediatric patients with newly diagnosed ALK‐positive ALCL.62